Scientific Advisory Board

Prof. Dr. Rolf Zinkernagel

Prof. Dr. Rolf Zinkernagel is Professor Emeritus at the University of Zurich, University Hospital, Zurich and former head of the Institute of Experimental Immunology, Zurich.

Prof. Dr. Hans Hengartner

Prof. Dr. Hans Hengartner is Professor Emeritus at the Federal Institute of Technology ETH Zurich and University of Zurich.

Özlem Türeci, Ph.D.

Özlem Türeci, Ph.D. is an MD with over 20 years’ experience in cancer research. Her focus is the identification of immunotherapeutic drug targets and development of antibody as well as vaccine based therapies for non-hematological cancers.

Supervisory Board

BioNTech is supported by an experienced Supervisory Board with a strong track record of pharmaceutical research, business development and clinical product development.

Helmut Jeggle

Helmut Jeggle is responsible for the life science initiatives of the Strüngmann brothers. Previously, he was the Head of Business Planning & Analyses at Hexal AG and is currently member of numerous Supervisory Boards.

Michael Motschmann

Michael Motschmann has been an entrepreneur for over 20 years. He has been actively involved in the creation and development of several companies.

Prof. Dr. Christoph Huber

Prof. Dr. Christoph Huber is a co-founder of BioNTech AG. He is Professor Emeritus at the Johannes-Gutenberg University Mainz, and former head of the Department of Hematology and Oncology at the Mainz University Medical Center.